+关注
AppleW
暂无个人介绍
IP属地：北京
57
关注
1
粉丝
1
主题
0
勋章
主贴
热门
AppleW
2021-08-26
看来这支股票要涨啊
众巢医学布局卵巢癌市场，医药行业又一片新蓝海？
去老虎APP查看更多动态
{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":3537159488676899,"uuid":"3537159488676899","gmtCreate":1574218056458,"gmtModify":1621479719840,"name":"AppleW","pinyin":"applew","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/03a4df2e4c49dab2c68408d77c565982","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":57,"tweetSize":1,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":1,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-3","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"偶像虎友","description":"加入老虎社区1500天","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.12.30","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"93.23%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.56%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":5,"crmLevelSwitch":0,"location":"北京","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":810669772,"gmtCreate":1629972510396,"gmtModify":1629972510396,"author":{"id":"3537159488676899","authorId":"3537159488676899","name":"AppleW","avatar":"https://static.tigerbbs.com/03a4df2e4c49dab2c68408d77c565982","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"看来这支股票要涨啊","listText":"看来这支股票要涨啊","text":"看来这支股票要涨啊","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/810669772","repostId":"2162706267","repostType":2,"repost":{"id":"2162706267","pubTimestamp":1629959373,"share":"https://www.laohu8.com/m/news/2162706267?lang=&edition=full","pubTime":"2021-08-26 14:29","market":"us","language":"zh","title":"众巢医学布局卵巢癌市场，医药行业又一片新蓝海？","url":"https://stock-news.laohu8.com/highlight/detail?id=2162706267","media":"美股研究社","summary":"美股研究社获悉，据智通财经消息，众巢医学8月26日宣布，其子公司上海众芯医疗科技有限公司为择优乐享-患者援助项目的卵巢癌患者提供随访管理服务，帮助卵巢癌患者提高治疗效果，并最终提高生存率。另外，一体化系统中的数字随访功能允许患者管理专员和医生对患者进行一对一用药指导和生活方式建议，确保患者正确地用药和应对不良反应，从而改善治疗体验。","content":"<html><body><article><p>美股研究社获悉，据智通财经消息，<a href=\"https://laohu8.com/S/ZCMD\">众巢医学</a>(ZCMD.US)8月26日宣布，其子公司上海众芯医疗科技有限公司(简称“众芯医疗”)为择优乐享-患者援助项目(简称“项目”)的卵巢癌患者提供随访管理服务，帮助卵巢癌患者提高治疗效果，并最终提高生存率。</p><img src=\"https://fid-75186.picgzc.qpic.cn/20210826145745990d1546f3mlgya5ui\"/><p>项目由白求恩慈善基金会管理，向符合尼拉帕利，一种抗癌药物，适应症的中国女性患者提供援助。通过公司自主研发的一体化患者管理服务系统(简称“一体化系统”)，患者可以记录，追踪和查看自己用药过程中的身体和疾病的各项指标，并收到潜在疾病进展的预警，以管理用药期间出现的不良反应和心理问题，并提高她们的诊疗依从性及治疗安全性。另外，一体化系统中的数字随访功能允许患者管理专员和医生对患者进行一对一用药指导和生活方式建议，确保患者正确地用药和应对不良反应，从而改善治疗体验。根据GlobalData的数据，2018年美国、法国、德国、意大利、西班牙、英国和日本七个主要市场的卵巢癌市场规模为18亿美元，预计未来十年将增长到67亿美元，年复合增长率为14.4%。</p><p></p></article></body></html>","source":"tencent","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>众巢医学布局卵巢癌市场，医药行业又一片新蓝海？</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n众巢医学布局卵巢癌市场，医药行业又一片新蓝海？\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-26 14:29 北京时间 <a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202108261457467a5a5026&s=b><strong>美股研究社</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>美股研究社获悉，据智通财经消息，众巢医学(ZCMD.US)8月26日宣布，其子公司上海众芯医疗科技有限公司(简称“众芯医疗”)为择优乐享-患者援助项目(简称“项目”)的卵巢癌患者提供随访管理服务，帮助卵巢癌患者提高治疗效果，并最终提高生存率。项目由白求恩慈善基金会管理，向符合尼拉帕利，一种抗癌药物，适应症的中国女性患者提供援助。通过公司自主研发的一体化患者管理服务系统(简称“一体化系统”)，患者...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202108261457467a5a5026&s=b\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/3153c88188d79bb8182b93c4fdd43636","relate_stocks":{"ZCMD":"众巢医学"},"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202108261457467a5a5026&s=b","is_english":false,"share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","article_id":"2162706267","content_text":"美股研究社获悉，据智通财经消息，众巢医学(ZCMD.US)8月26日宣布，其子公司上海众芯医疗科技有限公司(简称“众芯医疗”)为择优乐享-患者援助项目(简称“项目”)的卵巢癌患者提供随访管理服务，帮助卵巢癌患者提高治疗效果，并最终提高生存率。项目由白求恩慈善基金会管理，向符合尼拉帕利，一种抗癌药物，适应症的中国女性患者提供援助。通过公司自主研发的一体化患者管理服务系统(简称“一体化系统”)，患者可以记录，追踪和查看自己用药过程中的身体和疾病的各项指标，并收到潜在疾病进展的预警，以管理用药期间出现的不良反应和心理问题，并提高她们的诊疗依从性及治疗安全性。另外，一体化系统中的数字随访功能允许患者管理专员和医生对患者进行一对一用药指导和生活方式建议，确保患者正确地用药和应对不良反应，从而改善治疗体验。根据GlobalData的数据，2018年美国、法国、德国、意大利、西班牙、英国和日本七个主要市场的卵巢癌市场规模为18亿美元，预计未来十年将增长到67亿美元，年复合增长率为14.4%。","news_type":1},"isVote":1,"tweetType":1,"viewCount":1106,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3537218695872534","authorId":"3537218695872534","name":"山谷来风","avatar":"https://static.tigerbbs.com/e25745082a175af4e9f814d2e9d3bd37","crmLevel":2,"crmLevelSwitch":0},"content":"真的假的？ 不过这支股票价格的确不高。","text":"真的假的？ 不过这支股票价格的确不高。","html":"真的假的？ 不过这支股票价格的确不高。"}],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":810669772,"gmtCreate":1629972510396,"gmtModify":1629972510396,"author":{"id":"3537159488676899","authorId":"3537159488676899","name":"AppleW","avatar":"https://static.tigerbbs.com/03a4df2e4c49dab2c68408d77c565982","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"看来这支股票要涨啊","listText":"看来这支股票要涨啊","text":"看来这支股票要涨啊","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/810669772","repostId":"2162706267","repostType":2,"isVote":1,"tweetType":1,"viewCount":1106,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3537218695872534","authorId":"3537218695872534","name":"山谷来风","avatar":"https://static.tigerbbs.com/e25745082a175af4e9f814d2e9d3bd37","crmLevel":2,"crmLevelSwitch":0},"content":"真的假的？ 不过这支股票价格的确不高。","text":"真的假的？ 不过这支股票价格的确不高。","html":"真的假的？ 不过这支股票价格的确不高。"}],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}
